Skip to content

Study on the correlation between the excitatory changes of bilateral M1 region of brain and neuropathic pain after spinal cord injury

Study on the correlation between the excitatory changes of bilateral M1 region of brain and neuropathic pain after spinal cord injury

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080405
Enrollment
Unknown
Registered
2024-01-29
Start date
2024-03-01
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal cord injury

Interventions

Healthy control group:None
NNP group:None

Sponsors

Xijing Hospital, the First Affiliated Hospital of Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients: 1. 18-70 years old, right hand dominant (Edinburgh Handedness Inventory); 2. has been diagnosed with SCI; 3. post-injured course of disease: the cross-sectional study is limited to 36 months, and the cohort study is limited to 1 week to 1 month (has passed the spinal shock period); 4. The patient did not receive any form of rTMS treatment within 2 weeks; 5. no cognitive impairment (Mini-Mental State Examination>=24 scores); 6. Patients in NP group also need to meet the following requirements: ? definite diagnosis of neuropathic pain according to NeuPSIG/IASP grading system; ? new pain caused by spinal cord injury; 7. agree to participate in this experiment and sign the informed consent form. Healthy controls: 1. 18-70 years old, matched with SCI patients; 2. right hand dominant (Edinburgh Handedness Inventory); 3. no cognitive impairment (Mini-Mental State Examination>=24 scores); 4. agree to participate in this experiment and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Patients:1. severe cognitive or language impairment; 2.the presence of conductive, ferromagnetic or other magnetically sensitive metals in the head or neck or the presence of a pacemaker; 3. seizures within the last six months; 4. serious local or systemic diseases, unable to tolerate relevant tests; 5. other types of pain (such as skeletal muscle pain, visceral pain and other non-neuropathic pain); 6. taking the drugs that may affect the MEP recording within 1 week, including baclofen, diazepam and other drugs; 7. female patients are in the menstrual period. Healthy controls:1.the presence of conductive, ferromagnetic or other magnetically sensitive metals in the head or neck or the presence of a pacemaker;2.present history of acute or chronic pain;3.taking the drugs that may affect the MEP recording within 1 week, including baclofen, diazepam and other drugs; 4. female patients are in the menstrual period.

Design outcomes

Primary

MeasureTime frame
Single pulse transcranial magnetic stimulation, spTMS;Paired pulsed transcranial magnetic stimulation, ppTMS;Functional near-infrared spectroscopy, fNIRS;High-density electroencephalogram, hdEEG;Numeric rating scale, NRS;Short-form MeGill pain questionnaire-2, SF-MPQ-2;

Secondary

MeasureTime frame
Magnetic Resonance Spectroscopy,MRS;Somatosensory evoked potential, SEP;DN4 Neuropathic Pain Scale;Mechanical pain threshold;Pain and temperature threshold;Dynamic mechanical allodynia, DMA;Hyperpathia;Location and extent of pain;

Countries

China

Contacts

Public ContactHua Yuan

Xijing Hospital, the First Affiliated Hospital of Air Force Medical University

yuanhua@fmmu.edu.cn+86 29 8477 5439

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026